Jeffrey D Chulay from Southern Pines, NC, age 77

Name / Title

Company / Classification

Phones & Addresses

Jeffrey David Chulay

Jeffrey Chulay MD
Internist

2255 E Connecticut Ave, Southern Pines, NC 28387
352-372-3212

Jeffrey Chulay
Board of Directors

Sanaria Inc.
Biotechnology · Mfg Biological Products · Services-Misc · Medical Laboratories

9800 Medical Ctr Drive, Suitea209, Rockville, MD 20850
12115 Parklawn Dr, Rockville, MD 20852
301-770-3222, 301-770-7343, 301-770-5554

Medicine Doctors

Dr. Jeffrey D Chulay, Gainesville FL - MD (Doctor of Medicine)

view source

Specialties:

Infectious Disease Medicine

Address:

4525 Sw 97Th Ter, Gainesville, FL 32608
352-372-3212 (Phone)

Certifications:

Infectious Disease, 1978
Internal Medicine, 1973

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1970
Medical School
Cleveland Metropolitan General Hospital
Graduated: 1970
Medical School
Walter Reed Army Medical Center
Graduated: 1970

Jeffrey David Chulay

view source

Specialties:

Internal Medicine
Infectious Disease

Education:

Northwestern University (1970)

Resumes

Chief Medical Officer And Vice President Of Regulatory Affairs

view source

Location:

12085 Research Dr, Alachua, FL 32615

Industry:

Biotechnology

Work:

AGTC
Vice President and CMO
AlphaVax 2001 - 2007
Chief Medical Officer

Us Patents

Combination Preparation For Treating Malaria
view source
US Patent:

6413993, Jul 2, 2002
Filed:

Oct 9, 2001
Appl. No.:

09/958402
Inventors:

Jeffrey David Chulay - Durham NC
Assignee:

SmithKline Beecham Corporation - Philadelphia PA
International Classification:

A61K 3115
US Classification:

514350, 514565, 514682, 514892
Abstract:

Methods of treatment and prevention of malarial infection caused by , in which combinations of atovaquone, proguanil and primaquine are administered to a patient.

Alpha Virus-Based Cytomegalovirus Vaccines
view source
US Patent:

7419674, Sep 2, 2008
Filed:

Jul 8, 2004
Appl. No.:

10/886773
Inventors:

Jeffrey D. Chulay - Chapel Hill NC, US
Sergey Dryga - Chapel Hill NC, US
Elizabeth A. Reap - Durham NC, US
Robert A. Olmsted - Chapel Hill NC, US
John S. Morris - Cary NC, US
Assignee:

Alpha Vax, Inc. - Research Triangle Park NC
International Classification:

A61K 39/295
A61K 39/245
C12N 7/01
C12N 15/86
US Classification:

4241991, 4241921, 4242301, 4352351, 4353201
Abstract:

The present invention provides methods and compositions comprising a population of alphavirus replicon particles comprising alphavirus replicon RNAs, wherein a first replicon RNA comprises nucleic acid encoding cytomegalovirus pp65 and IE1 protein or immunogenic fragments thereof, and a second replicon RNA comprises nucleic acid encoding cytomegalovirus gB protein or an immunogenic fragment thereof, and wherein each of the two replicon RNAs is contained within a separate alphavirus replicon particle.

Methods And Compositions For Inducing Immune Responses And Protective Immunity By Priming With Alpha Virus Replicon Vaccines
view source
US Patent:

20050031592, Feb 10, 2005
Filed:

Nov 13, 2003
Appl. No.:

10/706088
Inventors:

Denise Doolan - Rockville MD, US
Gary Brice - McKees Rock PA, US
Carlota Dobano-Lazaro - Barcelom, ES
Jeffrey Chulay - Chapel Hill NC, US
Kurt Kamrud - Apex NC, US
Jonathan Smith - Cary NC, US
International Classification:

A61K048/00
A61K039/002
US Classification:

424093200, 424191100
Abstract:

The inventive subject matter relates to an immunogenic composition and method of immunizing a subject against malarial disease comprising administering to the subject a priming immunization preparation comprising alphavirus replicons expressing a gene encoding a malarial antigen or combination of malarial antigens and subsequently administering to the subject a boosting immunization preparation comprising the malarial antigen(s) or an expression system containing the antigen(s). The inventive composition and methods result in a robust induction of humoral and cellular immune system responses, including CD8, CD4 and antibody responses.

Enhancement Of Vaccine-Induced Immune Responses And Protection By Heterologous Boosting With Alphavirus Replicon Vaccines
view source
US Patent:

20050208020, Sep 22, 2005
Filed:

Nov 10, 2004
Appl. No.:

10/988403
Inventors:

Denise Doolan - Rockville MD, US
Gary Brice - , US
Daniel Carucci - Washington DC, US
Kurt Kamrud - Apex NC, US
Jeffrey Chulay - Chapel Hill NC, US
Jonathan Smith - Cary NC, US
International Classification:

A61K048/00
A61K039/12
US Classification:

424093200, 424199100
Abstract:

The inventive subject matter relates to an immunogenic composition and method of enhancing immunogenicity and protective immunity induced by any subunit or whole organism vaccine or combination of vaccines comprising administering to the subject a priming immunization preparation containing an antigen or fragment thereof, said preparation being selected from the group consisting of: a recombinant virus expression system; a recombinant protein antigen or a recombinant polypeptide; a synthetic peptide; a polynucleotide vector; a whole organism or extract and combinations thereof; and a boosting immunization of at least one alphavirus replicon containing an antigen or fragment thereof. The inventive subject matter further relates to an immunogenic composition and method of inducing an immune response that activates both cellular and humoral arms of the immune system.

Promoters, Expression Cassettes, Vectors, Kits, And Methods For The Treatment Of Achromatopsia And Other Diseases
view source
US Patent:

20130317091, Nov 28, 2013
Filed:

Jul 8, 2013
Appl. No.:

13/936728
Inventors:

Guo-Jie Ye - Gainesville FL, US
Jeffrey D. Chulay - Gainesville FL, US
International Classification:

C12N 15/85
US Classification:

514 44 R, 536 241, 4353201
Abstract:

The present invention provides isolated promoters, transgene expression cassettes, vectors, kits, and methods for treatment of genetic diseases that affect the cone cells of the retina.

Antigenic Determinants Recognized By Antibodies Obtained Using A Pathogenic Agent Or A Derivative Thereof That Presents A Restricted Set Of Antigens
view source
US Patent:

49065645, Mar 6, 1990
Filed:

Mar 13, 1987
Appl. No.:

7/025741
Inventors:

Jeffery A. Lyon - Silver Spring MD
Jeffrey L. Chulay - Washington DC
Alan W. Thomas - Silver Spring MD
Russell J. Howard - Los Altos Hills CA
James L. Weber - Marshfield WI
Assignee:

The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:

G01N 33561
G01N 33569
US Classification:

435 7
Abstract:

A method provides peptides that are antigenic determinants identified by antibodies obtained using intact pathogenic agents that present a restricted set of antigens to surveillance by the immune system.

Promoters, Expression Cassettes, Vectors, Kits, And Methods For The Treatment Of Achromatopsia And Other Diseases
view source
US Patent:

20190002913, Jan 3, 2019
Filed:

Apr 23, 2018
Appl. No.:

15/960048
Inventors:

- Alachua FL, US
Jeffrey D. Chulay - Southern Pines NC, US
International Classification:

C12N 15/85
C07K 14/705
A61K 48/00
Abstract:

The present invention provides isolated promoters, transgene expression cassettes, vectors, kits, and methods for treatment of genetic diseases that affect the cone cells of the retina.